galectin-3 inhibitors (Henry Ford Health System/G3 Pharmaceuticals)

N/A

Report date: 2025/01/26 18:56:19

Base Information

Drug Namegalectin-3 inhibitors (Henry Ford Health System/G3 Pharmaceuticals)
Drug Alias Namemodified citrus pectin (Henry Ford Health System/G3 Pharmaceuticals)
ClassificationNatural product/ExtractBiologics
Mechanisms of ActionGalectin-3 inhibitors
TargetsGalectin-3
Therapy Area/IndicationsHeart Failure, Diastolic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHenry Ford Health System
China Registration ClassN/A

Develop Information

Active CompaniesG3 Pharmaceuticals LtdHenry Ford Health System
Inactive CompaniesN/A
Active IndicationsHeart Failure, Diastolic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A